[Federal Register Volume 70, Number 163 (Wednesday, August 24, 2005)]
[Notices]
[Pages 49620-49621]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 05-16762]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Solicitation of the Nomination of Candidates To Serve as Members 
of the National Vaccine Advisory Committee

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of Public Health and Science.

ACTION: Notice.

-----------------------------------------------------------------------

    Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health 
Service (PHS) Act, as amended. The Committee is governed by the 
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2), 
which sets forth standards for the formation and use of advisory 
committees.

SUMMARY: The National Vaccine Program Office (NVPO), a program office 
within the Office of Public Health and Science, DHHS, is soliciting 
nominations of qualified candidates to be considered for appointment as 
members and representatives to the National Vaccine Advisory Committee 
(NVAC). The activities of this Committee are governed by the Federal 
Advisory Committee Act (FACA).
    Consistent with the National Vaccine Plan, the Committee advises 
and makes recommendations to the Assistant Secretary for Health in his/
her capacity as the Director of the National Vaccine Program, on 
matters related to the Program's responsibilities. Specifically, the 
Committee studies and recommends ways to encourage the availability of 
an adequate supply of safe and effective vaccination products in the 
United States; recommends research priorities and other measures to 
enhance the safety and efficacy of vaccines. The Committee also advises 
the Assistant Secretary for Health in the implementation of Sections 
2102 and 2103 of the PHS Act; and identifies annually the most 
important areas of government and non-government cooperation that 
should be considered in implementing Sections 2102 and 2103 of the PHS 
Act.

DATES: Nominations for membership on the Committee must be received no 
later than 5 p.m. EST on October 3, 2005, at the address below.

ADDRESSES: All nominations should be mailed or delivered to Bruce G. 
Gellin, M.D., M.P.H., Executive Secretary, National Vaccine Advisory 
Committee, Office of Public Health and Science, Department of Health 
and Human Services, 200 Independence Avenue, SW., Room 443-H, Hubert H. 
Humphrey Building; Washington, DC 20201.

FOR FURTHER INFORMATION CONTACT: Ms. Emma English, Program Analyst, 
National Vaccine Program Office, Department of Health and Human 
Services, 200 Independence Avenue, SW., Room 443-H, Hubert H. Humphrey 
Building, Washington, DC 20201; (202) 690-5566; <a href="/cdn-cgi/l/email-protection#88e6fee9ebc8e7fbe7f8e0fba6ece0e0fba6efe7fe"><span class="__cf_email__" data-cfemail="f39d859290b39c809c839b80dd979b9b80dd949c85">[email protected]</span></a>.
    A copy of the Committee charter and list of the current membership 
can be obtained by contacting Ms. English or by accessing the NVAC Web 
site at: http://www.hhs.gov/nvpo/nvac.

SUPPLEMENTARY INFORMATION:

[[Page 49621]]

    Committee Function: Qualifications and Information Required: As 
part of an ongoing effort to enhance deliberations and discussions with 
the public on vaccine and immunization policy, nominations are being 
sought for interested individuals to serve on the Committee. 
Individuals selected for appointment to the Committee will serve as 
voting members or representatives. Voting members shall be selected 
from individuals who are engaged in vaccine research or the manufacture 
of vaccines, or who are physicians, members of parent organizations 
concerned with immunizations, representatives of State or local health 
agencies or public health organizations. Voting representatives are 
official representatives of the vaccine manufacturing industry who are 
engaged in vaccine research or the manufacture of vaccines. Individuals 
selected for appointment to the Committee can be invited to serve terms 
with periods of up to four years.
    Nominations should be typewritten. The following information should 
be included in the package of material submitted for each individual 
being nominated for consideration: (1) A letter of nomination that 
clearly states the name and affiliation of the nominee, the basis for 
the nomination (i.e., specific attributes which qualify the nominee for 
service in this capacity), and a statement that the nominee is willing 
to serve as a member of the Committee; (2) the nominator's name, 
address and daytime telephone number, and the home and/or work address, 
telephone number, and email address of the individual being nominated; 
and (3) a current copy of the nominee's curriculum vitae. Applications 
cannot be submitted by facsimile. The names of Federal employees should 
not be nominated for consideration of appointment to this Committee.
    The Department makes every effort to ensure that the membership of 
HHS Federal advisory committees is fairly balanced in terms of points 
of view represented and the committee's function. Every effort is made 
that a broad representation of geographic areas, gender, ethnic and 
minority groups, and the disabled are given consideration for 
membership on HHS Federal advisory committees. Appointment to this 
committee shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, disability, and cultural, 
religious, or socioeconomic status.

    Dated: August 18, 2005.
Bruce Gellin,
Director, National Vaccine Program Office.
[FR Doc. 05-16762 Filed 8-23-05; 8:45 am]
BILLING CODE 4150-44-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>